Cited by 481Immunotherapy and Immune ResponsesImmune responses and vaccinationsHIV Research and Treatment

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

Heterologous prime-boost vaccination

Open access

Lu, Shan·2009·Current Opinion in Immunology

DOI 10.1016/j.coi.2009.05.016PMC PMC3743086

Open this paper in CoChat — free account Open PDF

Abstract

An effective vaccine usually requires more than one time immunization in the form of prime-boost. Traditionally the same vaccines are given multiple times as homologous boosts. New findings suggested that prime-boost can be done with different types of vaccines containing the same antigens. In many cases such heterologous prime-boost can be more immunogenic than homologous prime-boost. Heterologous prime-boost represents a new way of immunization and will stimulate better understanding on the immunological basis of vaccines.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.coi.2009.05.016

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity
Shiver, J. W., Fu, T., Chen, L., Casimiro, D. R., Davies, M.-E., Evans, R. K., Zhang, Z., Simon, A. J., Trigona, W. L., Dubey, S. A., et al. (2002) · Nature · doi:10.1038/415331a · Cited by 1,173
Control of a Mucosal Challenge and Prevention of AIDS by a Multiprotein DNA/MVA Vaccine
Amara, R. R. (2001) · Science · doi:10.1126/science.1058915 · Cited by 1,110
The prime-boost strategy: exciting prospects for improved vaccination
Ramshaw, I. A., & Ramsay, A. J. (2000) · Immunology Today · doi:10.1016/s0167-5699(00)01612-1 · Cited by 373
Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus.
Girard, M. P., Kiény, M. P., Pinter, A., Barré‐Sinoussi, F., Nara, P. L., Kolbe, H. V. J., Kusumi, K., Chaput, A., Reinhart, T. A., & Muchmore, E. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.2.542 · Cited by 353
Protection of Macaques Against SIV Infection by Subunit Vaccines of SIV Envelope Glycoprotein gp160
Hu, S.-L., Abrams, K., Barber, G. N., Moran, P. A., Zarling, J. M., Langlois, A. J., Kuller, L., Morton, W. R., & Benveniste, R. Ė. (1992) · Science · doi:10.1126/science.1531159 · Cited by 335
Enhanced T-Cell Immunogenicity and Protective Efficacy of a Human Immunodeficiency Virus Type 1 Vaccine Regimen Consisting of Consecutive Priming with DNA and Boosting with Recombinant Fowlpox Virus
Kent, S. J., Zhao, A., Best, S. J., Chandler, J. D., Boyle, D. B., & Ramshaw, I. A. (1998) · Journal of Virology · doi:10.1128/jvi.72.12.10180-10188.1998 · Cited by 325
Effective Induction of Simian Immunodeficiency Virus-Specific Cytotoxic T Lymphocytes in Macaques by Using a Multiepitope Gene and DNA Prime-Modified Vaccinia Virus Ankara Boost Vaccination Regimen
Hanke, T., Samuel, R. V., Blanchard, T. J., Neumann, V. C., Allen, T. M., Boyson, J. E., Sharpe, S. A., Cook, N. M., Smith, G. L., Watkins, D. I., et al. (1999) · Journal of Virology · doi:10.1128/jvi.73.9.7524-7532.1999 · Cited by 304
An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses
Harari, A., Bart, P., Stöhr, W., Tapia, G., Garcia, M., Medjitna-Rais, E., Burnet, S., Cellerai, C., Erlwein, O. W., Barber, T., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071331 · Cited by 299
Priming for and induction of anti-poliovirus neutralizing antibodies by synthetic peptides
Emini, E. A., Jameson, B. A., & Wimmer, E. (1983) · Nature · doi:10.1038/304699a0 · Cited by 237
A group specific anamnestic immune reaction against HIV-1 induced by a candidate vaccine against AIDS
Zagury, D., Bernard, J., Cheynier, R., Desportes, I., Leonard, R., Fouchard, M., Réveil, B., Ittelé, D., Lurhuma, Z., Mbayo, K., et al. (1988) · Nature · doi:10.1038/332728a0 · Cited by 185

Show all 40 references

Sorted by citations

Items 401–480 of 480

Progress in development and application of H5/H7 avian influenza vaccines in China
Zeng, X., GuoBin, T. I. A. N., & HuaLan, C. H. E. N. (2023) · Scientia Sinica Vitae · doi:10.1360/ssv-2023-0144 · Cited by 1
Immunization with V987H-stabilized Spike glycoprotein protects K18-hACE2 mice and golden Syrian hamsters upon SARS-CoV-2 infection
Ávila‐Nieto, C., Vergara‐Alert, J., Amengual-Rigo, P., Ainsua‐Enrich, E., Brustolin, M., de la Concepción, M. L. R., Pedreño-López, N., Rodon, J., Urrea, V., Pradenas, E., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46714-w · Cited by 1
A phase II/III, randomized, double-blind, placebo-controlled trial to evaluate immunogenicity and safety of the Gam-COVID-Vac combined vector vaccine in the prophylactic treatment for SARS-СoV-2 infection in the United Arab Emirates
Hammadi, A. A. K. A., Alzaabi, A. A., Choker, H. B., Ibrahim, A. A., Ishaq, A., Mahboub, A. E., Dhaheri, R. S. A., Alzaabi, M. N., Collyns, T. A., ElGhazali, G. E., et al. (2025) · Vaccine X · doi:10.1016/j.jvacx.2025.100698 · Cited by 1
Antibody Responses Elicited by DNA Prime-Protein Boost HIV Vaccines: A Dissertation
Vaine, M. (2010) · eScholarship@UMassChan · doi:10.13028/ypgp-5r25 · Cited by 1
DNA Vaccines in Pigs: From Immunization to Antigen Identification
Accensi, F., Bosch-Camós, L., Monteagudo, P. L., & Rodrı́guez, F. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2168-4_6 · Cited by 1
Human Immunodeficiency Virus Vaccines
Girard, M. P., & Koff, W. C. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35761-6.00029-8 · Cited by 2
Requirements for the Induction of Broadly Neutralizing Antibodies against HIV-1 by Vaccination
Vzorov, A. N., & Lv, U. (2017) · Molecular Biology · doi:10.1134/s0026893317060176 · Cited by 1
A Comprehensive Review of Vaccines against Covid-19
Minh, P. H., Linh, V. K., Hải, N. T., & Tùng, B. T. (2021) · VNU Journal of Science Medical and Pharmaceutical Sciences · doi:10.25073/2588-1132/vnumps.4365 · Cited by 1
SARS-CoV-2 antibodies among health care workers from a children’s hospital
Svartz, A., Rial, M. J., Insúa, C., Stedile, G., Haleblian, E., Peverini, A., & Brunetto, O. (2022) · Archivos Argentinos de Pediatria · doi:10.5546/aap.2022-02595.eng · Cited by 1
Pandemic of Coronavirus 19: A Comprehensive Literature Review, Therapeutic Options and Possible Lessons from SARS-COV Therapy
Rao, J. (2021) · Open Access Journal of Pharmaceutical Research · doi:10.23880/oajpr-16000234
Bayesian inference for prediction of survival probability in prime‐boost vaccination regimes
Lu, Y., Carlin, B. P., & Seaman, J. W. (2023) · Statistics in Medicine · doi:10.1002/sim.9972 · Cited by 1
Imunizações pré-clínicas contra malária baseadas no Antígeno 1 de Membrana Apical (PvAMA-1): testes de protocolos homólogos e heterólogos de indução e reforço utilizando DNA plasmidial e/ou proteína recombinante
Vicentin, E. C. M. (2012) · doi:10.11606/t.9.2012.tde-21052013-170007 · Cited by 1
Rift Valley fever : development of diagnostics and vaccines
Näslund, J. (2010) · KTH Publication Database DiVA (KTH Royal Institute of Technology) · Cited by 1
Alphavirus replicon-based strategies for vaccination
Knudsen, M. (2014) · Figshare · Cited by 1
A novel strategy to express different antigens from one modified vaccinia Ankara vaccine vectorPreprint
Lauer, K. B., McKenzie, E. A., Hall, Y., Gowda, C. P. C., Klapper, P. E., Borrow, R., Vallely, P. J., Carroll, M. W., & Blanchard, T. J. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/191924 · Cited by 1
Two urgent needs in the battle against COVID-19Preprint
Franco, R., & Serrano‐Marín, J. (2021) · doi:10.31219/osf.io/8fkbg · Cited by 1
VACCINES
Hu, S., & Ho, R. J. Y. (2013) · doi:10.1002/9781118660485.ch14 · Cited by 1
Transient T cell expansion, activation, and proliferation in therapeutically vaccinated SIV+ macaques treated with N-803Preprint
Harwood, O. E., Balgeman, A. J., Weaver, A. J., Ellis-Connell, A. L., Weiler, A. M., Erickson, K. N., Matschke, L. M., Golfinos, A. E., Vezys, V., Skinner, P. J., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.07.08.499199 · Cited by 1
Exploring the complexity of functional hiv-1 specific t-cell responses and global virus-host genetic variability
Pérez, C. L. (2011) · Figshare
Nucleic Acid Vaccines
Buglione‐Corbett, R., Suschak, J. J., Wang, S., & Lu, S. (2013) · Wiley eBooks · doi:10.1002/9780470571224.pse516
Self-citation
Avaliação de estratégias de vacinação "prime-boost" na infecção experimental por Schistosoma mansoni empregando vacinas de DNA
Espíndola, M. S. (2011) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2011.tde-02062011-105929
Roles in innate immune receptors: Host : pathogen interactions and strengthening vaccines
Nyström, S. (2013) · Figshare
Estudo in silico das bases moleculares responsáveis pela reatividade cruzada entre epitopos virais restritos ao alelo HLA-A*02:01
Antunes, D. A. (2011) · Americanae (AECID Library)
Besser Impfen – neue Wege zur gezielten Immunmodulation bei Gesunden und Immunsupprimierten
Balmer, M. L., & Berger, C. T. (2014) · Therapeutische Umschau · doi:10.1024/0040-5930/a000476
Mucosal immunity against mycobacterial infection
Rahman, M. J. (2010) · DiVA (Stockholm University)
Elucidating the role of BCL6 in helper T cell activation, proliferation, and differentiation
Hollister, K. (2014) · IUScholarWorks (Indiana University) · doi:10.7912/c2/1738
Follicular Helper, Follicular Regulatory T cells and the Germinal Center In HIV Vaccine Development
Dent, A. L. (2015) · International Journal of Vaccines and Immunization · doi:10.16966/2470-9948.e101
A mechanistic analysis of DNA vaccine-induced tumor immunity against the viral oncoprotein simian virus 40 large tumor antigen
Aldrich, J. F. (2012) · ThinkTech (Texas Tech University)
Development and clinical translation of microneedles for insulin delivery and self-vaccination
Norman, J. J. (2012) · SMARTech Repository (Georgia Institute of Technology)
Evaluación de una vacuna de ADN y su péptido recombinante contra inhibina alfa (165-300) sobre la respuesta inmune y fertilidad en ratones
Luna‐Palomera, C., González-González, J., Gayosso-Vázquez, A., Ramírez-Andoney, V., Ojeda-Robertos, N. F., Cabrales, J. A. A., & Alonso-Morales, R. A. (2018) · Nova Scientia · doi:10.21640/ns.v10i20.1310
Desenvolvimento de uma estratégia vacinal dose-reforço heterológo baseada em linhagens recombinantes de Bacillus subitilis para o controle de Spreptococcus mutans.
da Silva, D. A. (2018) · doi:10.11606/d.42.2018.tde-25062018-115726
Towards the development of HAGE-based vaccines for the treatment of patients with triple negative breast cancers
Nagarajan, D. (2018) · Nottingham Trent University's Institutional Repository (Nottingham Trent Repository)
Rapid Synthetic DNA Vaccine Development for Emerging Infectious Disease Outbreaks
Louis, L., & Weiner, D. B. (2019) · Current cancer research · doi:10.1007/978-3-030-04155-7_16
Characterization of Rabbit Monoclonal Antibodies Produced by an HIV-1 Vaccine
Colpas, E. C. (2013) · Digital WPI
DEVELOPING NATURAL KILLER T CELL BASED TOOLS AND STRATEGIES FOR TARGETING BREAST CANCER
Gebremeskel, S. (2019) · DalSpace (Dalhousie University)
DNA adjuvant Amiloride conjunct long immunization interval promote higher antibody responses to HIV-1 gp41 and gp140 immunogens
Yao, L., Wang, J., Bao, L.-N., Fan, M.-X., Bai, Y., Chen, W., Chen, Y., Li, Y., Wang, J., Li, Y., et al. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.09.077
A COVID-19 Vaccines Review: What We Have Learned So Far and Where Do We Go from Here?Preprint
Wong, S. C. Y., & Morgenstern, C. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3812637
Développement de nouveaux adjuvants dérivés de pseudoparticules du virus de la mosaïque de la papaye
Savard, C. (2011)
A Field Study Evaluating Humoral Immunity in Calves Vaccinated with Multivalent Bovine Respiratory Pathogen Vaccines
Berge, A. C., Jozan, T., Levesque, C., & Vertenten, G. (2021) · Folia veterinaria · doi:10.2478/fv-2021-0034
An intranasal lentiviral booster broadens immune recognition of SARS-CoV-2 variants and reinforces the waning mRNA vaccine-induced immunity that it targets to lung mucosaPreprint
Vesin, B., Lopez, J., Noirat, A., Authié, P., Fert, I., le Chevalier, F., Moncoq, F., Nemirov, K., Blanc, C., Planchais, C., et al. (2022) · bioRxiv · doi:10.1101/2022.01.30.478159
Management of Medications Taken by Medically Complex Dental Patients
Weinberg, M. M. A., Froum, S., & Segelnick, S. L. (2020) · doi:10.1002/9781119539384.ch7
Nuevos retos en el desarrollo y uso de vacunas contra la COVID-19.
Esparza, J., García, A. H., Figuera, M. E., & Pujol, F. H. (2022) · Salus · doi:10.54139/salus.v25i3.126
Anticuerpos anti-SARS-CoV-2 en personal de salud de un hospital pediátrico
(2022) · Archivos Argentinos de Pediatria · doi:10.5546/aap.2022-02595
Different Platforms, Immune Response Modulators and Challenges in SARS-CoV-2 Vaccination
Portilho, A. I., Correa, V. A., Gaspar, E. B., & Gaspari, E. D. (2022) · Springer eBooks · doi:10.1007/978-3-031-08045-6_26
Latest in COVID-19 Vaccine 'Candidates' Race
Atoum, M. F. M., Zreig, D. A., & Zreig, L. M. A. (2022) · Infectious Disorders - Drug Targets · doi:10.2174/1871526522666220818124416
Canine Parainfluenza Virus Infection
Ellis, J. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-50934-3.00026-4
Immunotherapy and Cancer Stem Cells
Suryaprakash, R. T. C., Safi, M. A. A., Alonazi, N. A., Alsieedi, A. A., & Kujan, O. (2023) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815124606123010007
Comparing how the microenvironments of the skin and lung shape T cell responses to vaccination
Palmer, O. R. (2020) · doi:10.26686/wgtn.22806971
Epstein-Barr virus and neuroinflammation
Hassani, A., & Khan, G. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-85841-0.00013-4
Vaccine equity and access: A comparative assessment of Covaxin, Covishield, and Sputnik V.
Teli, A., Rathore, P., Kumar, R., & Alam, M. S. (2023) · Indian Journal of Pharmacy and Pharmacology · doi:10.18231/j.ijpp.2023.018
Genetic-Based Vaccine Vectors
Weiner, D. B., Jansen, K. U., & Villafana, T. L. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-79058-1.00068-2
Vacunación en neonatos contra la enfermedad resurgente pertussis: un desafío, una estrategia
Aispuro, P. M. (2021) · doi:10.35537/10915/160442
Evaluation of Modified Vaccinia virus Ankara based locoregional immunotherapy in peritoneal carcinomatosis models
Bella, Á. (2024) · Deposito Adademico Digital Universidad De Navarra (University of Navarra) · doi:10.15581/10171/69184
SARS-CoV2 and SARS-CoV2 vaccinology
Pinto, R., Kumar, A., & Sachin, K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15241-2.00010-7
COVID-19 hospitalization in vaccinated and non-vaccinated patients: Clinical profile and outcomes
Ferreira, L. H., Bitencourt, E., Gabardo, B. M. A., Pereira, S. E., Teixeira, F., Magatão, D. D. S., Dias, V. L., Petterle, R. R., Nogueira, M. B., & Raboni, S. M. (2025) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2025.104537
Immune responses to a heterologous booster with mRNA based COVID-19 vaccine after priming with an inactivated Newcastle disease virus recombinant vaccine expressing the SARS-CoV-2 spike protein (NDV-HXP-S)
Luvira, V., Lawpoolsri, S., Phumratanaprapin, W., Jongkaewwattana, A., Nanthapisal, S., Muangnoicharoen, S., Kamolratanakul, S., Sabmee, Y., Duangdee, C., Narakorn, P., et al. (2025) · Vaccine · doi:10.1016/j.vaccine.2025.127601
Single dose alum adjuvanted RBD protein vaccine provides protection against homologous challenge with SARS-CoV-2 Washington strain and heterologous rechallenge with Delta and Omicron BA.5 variants in K18 hACE2 mouse modelPreprint
Thippeshappa, R., Kulkarni, V., Dwivedi, V., McMillian, J., Argonza, M., Castro, J., Rodriguez, O. L., Maingot, B., Gaži, M., Meredith, R. J., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.18.677166
A pilot study on a heterologous prime-boost approach for inducing an immune response against double-layered human rotavirus particles
Alesheikh, S., Tazarghi, A., Tabarraei, A., Kianmehr, Z., Akhondi, S., Soleimanjahi, H., Azimi, S. A., & Nikoo, H. R. (2025) · BMC Research Notes · doi:10.1186/s13104-025-07592-7
Optimization of PLGA microspheres for immunotherapy of tumors in the mouse model
Müller, M. U. (2010)
Additional file 2 of Age and product dependent vaccine effectiveness against SARS-CoV-2 infection and hospitalisation among adults in Norway: a national cohort study, July–November 2021
Starrfelt, J., Danielsen, A. S., Buanes, E. A., Juvet, L. K., Lyngstad, T. M., Rø, G., Veneti, L., Watle, S. V., & Meijerink, H. (2022) · Figshare · doi:10.6084/m9.figshare.20786762
Additional file 1 of Age and product dependent vaccine effectiveness against SARS-CoV-2 infection and hospitalisation among adults in Norway: a national cohort study, July–November 2021
Starrfelt, J., Danielsen, A. S., Buanes, E. A., Juvet, L. K., Lyngstad, T. M., Rø, G., Veneti, L., Watle, S. V., & Meijerink, H. (2022) · Figshare · doi:10.6084/m9.figshare.20786759
DNA prime and peptide boost immunization elicits robust neoantigen-specific CD8 + T cell responses and therapeutic protection in mouse tumor models
Morgado-Cáceres, P., Hofmann-Vega, F., Figueroa, D. A., Saavedra-Almarza, J., Gálvez‐Cancino, F., Díaz, X., Menares, E., Roa, E., Hidalgo, S., Varas‐Godoy, M., et al. (2026) · OncoImmunology · doi:10.1080/2162402x.2025.2606497
Plasmablast, memory B cell and T follicular helper cell responses after human papillomavirus vaccination: effect of dose number and age
Kiamba, E. W., Ajiboye, D. O., Bashorun, A. O., Jallow, M. N., Drammeh, L., Bah, S., Jobarteh, T., Kanu, F. J., Jawla, O., Jobarteh, L., et al. (2026) · npj Vaccines · doi:10.1038/s41541-026-01408-w
Current landscape and domestic breakthroughs: A comprehensive review of pet vaccines in China
Zhang, L., Zhang, X., Guo, T., Du, W., Wang, S., & Li, Y. (2026) · Veterinary Vaccine · doi:10.1016/j.vetvac.2026.100158 · Cited by 1
RON4 et ROP18 deux protéines de rhoptries de Toxoplasma gondii candidats vaccins ? : Etude dans un modèle de toxoplasmose chronique chez la souris
Rashid, M. I. (2011) · theses.fr (ABES) · doi:10.70675/41c5fab1z6ac3z463cz898dz58299de04c16
Identification d'espèces moléculaires de lysophosphatidylcholine présentant des activités adjuvantes en vue d'un développement clinique
Bach, G. (2009) · theses.fr (ABES) · doi:10.70675/22af2565z5644z4927zba8aze016011299f3
Utilisation de cellules dendritiques en vaccination thérapeutique anti-VIH : approche expérimentale chez le macaque
Romain, G. (2011) · theses.fr (ABES) · doi:10.70675/1d544c1czed63z4e9ez931bzaecc5473998b
Development of therapeutic vaccine strategies and pre-clinical animal tumor models for head and neck cancers
Macedo, R. (2015) · theses.fr (ABES) · doi:10.70675/062de280z0f7az4982zb8dfz54b655a8886c
Développement d’immunothérapies contre l’antigène de tumeur universel hTERT basées sur différentes stratégies vaccinales
Pliquet, É. (2015) · theses.fr (ABES) · doi:10.70675/3d2918dcz5387z4f04za923zfcc09f199520
Etude de susceptibilité in vitro au benznidazole et à un nouvel agent en développement, JN034, des souches de Trypanosoma cruzi appartenant aux unités de typage distinctes : méta-analyse et profil préliminaire d’activité anti-Chagas
Vela, A. (2021) · doi:10.70675/0f8bfcd6z1572z4576z9235zbcc339c070f9
Caractérisation de la réponse lymphocytaire B mémoire contre le SARS-CoV-2 après infection ou vaccination
Sokal, A. (2022) · theses.fr (ABES) · doi:10.70675/00bd0a63z263fz470az876czb50b49ba4313
Heterologous DNA prime–crude tachyzoite lysate antigen boost targeting MIC8 confers protection against acute and chronic Toxoplasma gondii infection in mice
Mac, P. A., Ambu, S. P., Amalraj, F. D., Somanath, S. D., & Chakravarthi, S. (2026) · Vaccine · doi:10.1016/j.vaccine.2026.128554
Strategies to enhance DNA vaccine efficacy against emerging arboviruses: lessons from ZIKA and Chikungunya viruses
Sreekanth, S., & Lahon, A. (2026) · Vaccine · doi:10.1016/j.vaccine.2026.128680 · Cited by 1
Long-term cross-variant Fc-mediated immune responses against SARS-CoV-2 induced by a heterologous adenoviral/inactivated virus prime-boost vaccination strategy
Kim, D., Lee, J. H., Lee, J. C., Park, J. Y., Shin, Y., Kim, S. J., Cheon, B., Lee, S., Cho, E., Kim, D. R., et al. (2026) · npj Vaccines · doi:10.1038/s41541-026-01483-z
Heterologous prime-boost immunization with herpesvirus of turkeys vectored and inactivated vaccines elicits an early and long-term immunity against a lethal H5N1 virus in chickens
Chen, P., He, X., Bao, H., Wang, Y., Liu, Y., Yu, Q., Zhou, X., Li, W., Deng, G., Shi, J., et al. (2026) · Journal of Integrative Agriculture · doi:10.1016/j.jia.2026.06.009
Immunogenicity and protective efficacy on non-adjuvanted CD40-targeting SARS-CoV-2 vaccines in non-human primates
Marlin, R., Centlivre, M., Bossevot, L., Gallouët, A.-S., Alexandre, M., Planas, D., Cavarelli, M., Staropoli, I., Gros, W., Surénaud, M., et al. (2026) · EBioMedicine · doi:10.1016/j.ebiom.2026.106361 · Cited by 1
Integrating vaccine platforms and delivery routes to improve breadth of influenza immunity
Dharmapal, D., & Ross, T. M. (2026) · Vaccine X · doi:10.1016/j.jvacx.2026.100890
Spatiotemporal heterologous vaccination relies on type I interferons at priming to enhance mucosal immunity
Wiest, M. J., Laghlali, G., d’Acunzo, J., Chung, C., Karadağ, D., Yan, V., Park, S., Noureddine, M., Janczak, K. W., Chen, C., et al. (2026) · EMBO Molecular Medicine · doi:10.1038/s44321-026-00539-w
Malaria Vaccine in Healthy Adults
Trials, G. C. T. G. C. (2019) · ImmPort · doi:10.21430/m3fvo9sm7y
Characterization of Innate Immune Pathways in DNA Vaccine-Induced, Antigen-Specific Immune Responses: A Dissertation
Suschak, J. J. (2014) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/m29k5p

Authors: Lu, S.
Affiliations: Jiangsu Province Hospital (CN)
Corresponding author: Lu, Shan
ORCID: Lu, Shan
Venue: Current Opinion in Immunology
Publisher: Elsevier BV
Published: 2009-06
Volume: 21
Issue: 3
Pages: 346-351
ISSN: 0952-7915 (ISSN-L)
DOI: 10.1016/j.coi.2009.05.016
PMC: PMC3743086
OpenAlex: W1979742563
Cited by: 481
References: 40
Citations by year: 2026: 15 · 2025: 25 · 2024: 21 · 2023: 32 · 2022: 66 · 2021: 53 · 2020: 41 · 2019: 28 · 2018: 17 · 2017: 27 · 2016: 13 · 2015: 18 · 2014: 21 · 2013: 34 · 2012: 18
FWCI: 1.81
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
doi.org/10.15223/policy-017 (stm-asf)
doi.org/10.15223/policy-037 (stm-asf)
doi.org/10.15223/policy-012 (stm-asf)
doi.org/10.15223/policy-029 (stm-asf)
doi.org/10.15223/policy-004 (stm-asf)
Locations: Current Opinion in Immunology (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health
National Institute of Allergy and Infectious Diseases (P01AI082274, R01AI065250, R01 AI06250, U19AI082676)
Topics: Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
Keywords: heterologous prime-boost, prime-boost vaccination, vaccine immunogenicity, vaccine adjuvants
MeSH terms: Animals, Humans, Immunization, Secondary, Neoplasms, Research, Research Design, Vaccination, HIV Infections, AIDS Vaccines, Cancer Vaccines

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Heterologous prime-boost vaccination

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks